Výsledky vyhledávání - Norbert Bräu
- Zobrazuji výsledky 1 - 19 z 19
-
1
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy Autor Norbert Bräu, Mirella Salvatore, Carlos F. Ríos‐Bedoya, Alberto Fernández-Carbia, Fiorenzo Paronetto, José F. Rodríguez‐Orengo, M. Rodríguez‐Torres
Vydáno 2005Artigo -
2
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV–HIV International Panel Autor Vincent Soriano, Massimo Puoti, Mark Sulkowski, Antonietta Cargnel, Yves Benhamou, Marion G. Peters, Stefan Mauss, Norbert Bräu, Angelos Hatzakis, Stanislas Pol, Juergen Rockstroh
Vydáno 2007Revisão -
3
669 VALIDATION OF THE MESIAH SCORE AS PREDICTOR OF SURVIVAL IN HIV-INFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) Autor Nadeem A Qazi, Beatriz Mínguez, M Ventura, Maaz B. Badshah, Mukesh Kumar Jain, Melissa Harris, Lesli Taylor, Luciana Kikuchi, J. Marrero, Norbert Bräu
Vydáno 2013Artigo -
4
1065 IMPACT OF SCREENING FOR HEPATOCELLULAR CARCINOMA (HCC) IN HIV/HCV-COINFECTED PATIENTS ON STAGING, THERAPY AND SURVIVAL Autor Luciana Kikuchi, M. Núñnez, Pablo Barreiro, Mark Nelson, M.E. Vispo, Elizabeth Page, Massimo Puoti, Richard Fox, Morris Sherman, F.J. Carrilho, Norbert Bräu
Vydáno 2010Artigo -
5
Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co‐infection: Clinically relevant or a diagnostic problem? Autor M. Rodríguez‐Torres, Juan González‐García, Norbert Bräu, R. Solà, Santiago Moreno, Jürgen K. Rockstroh, Fiona Smaill, Maria Cássia Mendes-Corrêa, Jean DePamphilis, Francesca J. Torriani
Vydáno 2007Artigo -
6
Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepa... Autor Zobair M. Younossi, Maria Stepanova, Mark Sulkowski, Graham R. Foster, Nancy Reau, Alessandra Mangia, Keyur Patel, Norbert Bräu, Stuart K. Roberts, Nezam H. Afdhal, Fatema Nader, Linda Henry, Sharon Hunt
Vydáno 2016Artigo -
7
Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse Autor Samuel B. Ho, Norbert Bräu, Ramsey Cheung, Lin Liu, Courtney Sanchez, Marisa Sklar, Tyler E. Phelps, Sonja Marcus, M.M. Wasil, Amelia Tisi, Lia Huynh, Shannon K. Robinson, Allen L. Gifford, Steven M. Asch, Erik J. Groessl
Vydáno 2015Artigo -
8
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment Autor Edward Gane, Eric Lawitz, David Pugatch, George Papatheodoridis, Norbert Bräu, Ashley Brown, Stanislas Pol, Vincent Leroy, Marcello Persico, Christophe Moreno, Massimo Colombo, Eric M. Yoshida, David R. Nelson, Christine A. Collins, Lei Yang, Matthew P. Kosloski, Federico Mensa
Vydáno 2017Artigo -
9
Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data Autor Jessie Torgersen, Alyssa Mezochow, Craig Newcomb, Dena M. Carbonari, Sean Hennessy, Christopher T. Rentsch, Lesley S. Park, Janet P. Tate, Norbert Bräu, Debika Bhattacharya, Joseph K. Lim, Catherine Mezzacappa, Basile Njei, Jason Roy, Tamar H. Taddei, Amy C. Justice, Vincent Lo Re
Vydáno 2024Carta -
10
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study Autor David Wyles, Norbert Bräu, Shyam Kottilil, Eric S. Daar, Peter Ruane, Kimberly Workowski, Anne F. Luetkemeyer, Oluwatoyin Adeyemi, Arthur Y. Kim, Brian Doehle, Kaijiao Huang, Erik Mogalian, Anu Osinusi, John McNally, Diana M. Brainard, John G. McHutchison, Susanna Naggie, Mark Sulkowski
Vydáno 2017Artigo -
11
The albumin‐bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in <scp>HIV</scp>‐associated hepatocellular carcinoma Autor David J. Pinato, Rohini Sharma, Caitlin Citti, Heather Platt, Meritxell Ventura‐Cots, Elias Allara, Tsai‐Yun Chen, Alessia Dalla Pria, Mamta K. Jain, Beatriz Mínguez, Luciana Kikuchi, E West, Marco Merli, D. E. Kaplan, Hamid Hasson, Kristen Marks, Mark Nelson, Marina Núñez, Ayse Aytaman, Mark Bower, Norbert Bräu
Vydáno 2017Artigo -
12
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study Autor David J. Pinato, Elias Allara, Ting-Yi Chen, Franco Trevisani, Beatriz Mínguez, Marco Zoli, Marianne Harris, Alessia Dalla Pria, Nicolás Merchante, Heather Platt, Mamta K. Jain, Eugenio Caturelli, Luciana Kikuchi, Juan A. Pineda, Mark Nelson, Fabio Farinati, Gian Ludovico Rapaccini, Ayse Aytaman, Michael T. Yin, Chee‐Kiat Tan, Mark Bower, Edoardo G. Giannini, Norbert Bräu
Vydáno 2018Artigo -
13
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection Autor Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo, Mario Chojkier, Norman Gitlin, Massimo Puoti, Manuel Romero‐Gómez, Jean-Pierre Zarski, Kosh Agarwal, Peter Buggisch, Graham R. Foster, Norbert Bräu, Marı́a Buti, Ira M. Jacobson, G. Mani Subramanian, Xiao Ding, Hongmei Mo, Jenny C. Yang, Phillip S. Pang, William T. Symonds, John G. McHutchison, Andrew J. Muir, Alessandra Mangia, Patrick Marcellin
Vydáno 2014Artigo -
14
Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia Autor Iván O. Rosas, Norbert Bräu, Michael R. Waters, Ronaldo C. Go, Bradley D. Hunter, Sanjay Bhagani, Daniel J. Skiest, Mariam Aziz, Nichola Cooper, Ivor S. Douglas, Sinisa Savic, Taryn Youngstein, Lorenzo Del Sorbo, Antonio Cubillo Gracián, David J. De La Zerda, Andrew Ustianowski, Min Bao, Sophie Dimonaco, Emily Graham, Balpreet Matharu, Helen Spotswood, Larry Tsai, Atul Malhotra
Vydáno 2020Pré-impressão -
15
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia Autor Iván O. Rosas, Norbert Bräu, Michael R. Waters, Ronaldo C. Go, Bradley D. Hunter, Sanjay Bhagani, Daniel J. Skiest, Mariam Aziz, Nichola Cooper, Ivor S. Douglas, Sinisa Savic, Taryn Youngstein, Lorenzo Del Sorbo, Antonio Cubillo Gracián, David J. De La Zerda, Andrew Ustianowski, Min Bao, Sophie Dimonaco, Emily Graham, Balpreet Matharu, Helen Spotswood, Larry Tsai, Atul Malhotra
Vydáno 2021Artigo -
16
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1 Autor Susanna Naggie, Curtis Cooper, Michael S. Saag, Kimberly Workowski, Peter Ruane, William Towner, Kristen Marks, Anne F. Luetkemeyer, Rachel Baden, Paul E. Sax, Edward Gane, Jorge Santana‐Bagur, Luisa M. Stamm, Jenny C. Yang, Polina German, Hadas Dvory‐Sobol, Liyun Ni, Phillip S. Pang, John G. McHutchison, Catherine Stedman, Javier O Morales-Ramirez, Norbert Bräu, Dushyantha Jayaweera, Amy E. Colson, Pablo Tebas, David Wong, Douglas T. Dieterich, Mark Sulkowski
Vydáno 2015Artigo -
17
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials Autor Ira M. Jacobson, Eric Lawitz, Edward Gane, Bernard E Willems, Peter Ruane, Ronald Nahass, Sergio Borgia, Stephen D. Shafran, Kimberly Workowski, Brian L. Pearlman, Robert H. Hyland, Luisa M. Stamm, Evguenia S. Svarovskaia, Hadas Dvory‐Sobol, Yanni Zhu, G. Mani Subramanian, Diana M. Brainard, John G. McHutchison, Norbert Bräu, Thomas Berg, Kosh Agarwal, Bal Raj Bhandari, Mitchell Davis, Jordan J. Feld, Gregory J. Dore, Catherine Stedman, Alexander Thompson, Tarik Asselah, Stuart K. Roberts, Graham R. Foster
Vydáno 2017Artigo -
18
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection Autor Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts, Norbert Bräu, Edward Gane, Stephen Pianko, Eric Lawitz, A. Thompson, Mitchell L. Shiffman, Curtis Cooper, William Towner, Brian Conway, Peter Ruane, Marc Bourlière, Tarik Asselah, Thomas Berg, Stefan Zeuzem, William Rosenberg, Kosh Agarwal, Catherine Stedman, Hongmei Mo, Hadas Dvory‐Sobol, Lingling Han, Jing Wang, John McNally, Anu Osinusi, Diana M. Brainard, John G. McHutchison, Francesco Mazzotta, Tram T. Tran, Stuart C. Gordon, Keyur Patel, Nancy Reau, Alessandra Mangia, Mark Sulkowski
Vydáno 2015Artigo -
19
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) Autor Iván O. Rosas, Norbert Bräu, Michael R. Waters, Ronaldo C. Go, Atul Malhotra, Bradley D. Hunter, Sanjay Bhagani, Daniel J. Skiest, Sinisa Savic, Ivor S. Douglas, Julia Garcia‐Diaz, Mariam Aziz, Nichola Cooper, Taryn Youngstein, Lorenzo Del Sorbo, David J. De La Zerda, Andrew Ustianowski, Antonio Cubillo Gracián, Kevin G. Blyth, Jordi Carratalà, Bruno François, Thomas Benfield, Derrick S. Haslem, Paolo Bonfanti, Cor H. van der Leest, Nidhi Rohatgi, Lothar Wiese, Charles Edouard Luyt, Rebecca N. Bauer, Fang Cai, Ivan T. Lee, Balpreet Matharu, Louis M. Metcalf, Steffen Wildum, Emily Graham, Larry Tsai, Min Bao
Vydáno 2022Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Gastroenterology
Hepatitis C virus
Virus
Immunology
Hepatitis C
Virology
Ribavirin
Adverse effect
Human immunodeficiency virus (HIV)
Randomized controlled trial
Sofosbuvir
Cirrhosis
Confidence interval
Environmental health
Hepatocellular carcinoma
Population
Alternative medicine
Disease
Liver disease
Pathology
Pneumonia
Regimen
Tocilizumab
Antibody
Antiretroviral therapy
Bilirubin
Hazard ratio
Hepatitis B